Latest News

BioMarin to acquire Alesta Therapeutics for $275 million for potential rare bone disease treatment
BioMarin will acquire Alesta Therapeutics for $275 million upfront, and up to an additional $215 million based on milestones. Alesta Therapeutic's lead drug is a potential treatment for hypophosphatas

PLNT EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Planet Fitness (PLNT) Investors of Securities Class Action Lawsuit Deadline on September 14, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Planet Fitness To Contact Him Directly To Discuss Their Options If you purchased or a

RXT EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Rackspace Technology (RXT) Investors of Securities Class Action Lawsuit Deadline on September 28, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Rackspace To Contact Him Directly To Discuss Their Options If you purchased or acquir

WIX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Wix.com (WIX) Investors of Securities Class Action Lawsuit Deadline on September 22, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Wix To Contact Him Directly To Discuss Their Options If you purchased or acquired sec

Kaplan Fox Announces an Investigation into The Ensign Group, Inc. (ENSG) on Behalf of Investors
New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against The Ensign Group, Inc. ("Ensign" or the "Company") (NASDAQ

Blue Owl Technology Finance: Q2 Outperformance And Higher Income Catalysts
Blue Owl Technology Finance Corp (OTF) delivered a strong Q2, with a 2.4% total NAV return and robust share repurchases boosting NAV accretion. OTF's 13.9% dividend yield will reset lower as special d

WSE EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Wise Group plc (WSE) Investors of Securities Class Action Lawsuit Deadline on September 29, 2026
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Wise To Contact Him Directly To Discuss Their Options If you purchased or acquired se

Marvell shares jump as Google warrant deepens AI chip partnership
Marvell Technology Inc (NASDAQ:MRVL) issued Alphabet's Google a warrant to buy up to 58.97 million shares at $206.58 apiece, expanding a custom chip partnership between the two companies. The warrant

EyePoint: Sell-Off As Duravyu Fails Head-To-Head Study Vs Eylea May Be Overblown
Eyepoint Pharmaceuticals (EYPT) plunged 70% after its LUGANO Phase 3 trial for Duravyu in wet AMD failed the primary endpoint due to an anomalous cohort. EYPT's management argues the failure was driv

Kaplan Fox Notifies Wix.com Ltd. (WIX) Investors of an Upcoming Lead Plaintiff Deadline on September 22, 2026
New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Wix.com Ltd. ("Wix" or the "Company") (NASDAQ: WIX) on

Flash Sports & Media and Bongo CEOs to Appear on TraderTV Live
Toronto, Ontario--(Newsfile Corp. - August 19, 2026) - TraderTV Live is pleased to announce that Suren Ajjarapu, Chairman of Flash Sports & Media Holdings, Inc. (NASDAQ: FLZH), and Ahad Bhai, Chief Ex

Wendy's: A Takeover Potentially The Best Outcome For Stakeholders
Wendy's is a live take-out candidate, with Trian Partners, Flynn Group, and BlueFive Capital forming a buyout consortium. WEN's US sales and operating cash flows are declining, but its real estate hol

S&P500: Treasury Buyback Lifts US Stocks as Moderna Cancer Data Sparks Rally
US stocks rise as Treasury doubles long-bond buybacks, cutting yields and lifting the S&P 500 while Moderna soars on positive late-stage cancer vaccine data.

Jack Henry & Associates: One Of The Lowest Valuations In Years
Jack Henry & Associates, Inc. delivered a double beat in its latest earnings, with revenue and EPS surpassing consensus estimates. JKHY's full-year adjusted revenue grew 7%, and adjusted operating pro

GoGold: Derisked Transition, Set To Grow
GoGold Resources (GLGDF) is rated Buy as it transitions from Parral Tailings to the high-potential Los Ricos South mine. Parral remains the current revenue engine, funding Los Ricos development, with

Lexicon Pharmaceuticals Edging Closer To 'Go Time' On Multiple Late-Stage Assets
Lexicon Pharmaceuticals (LXRX) is nearing multiple potential value-transforming events for sotagliflozin, and the shares have been strong since my last update. Sotagliflozin, targeting HCM and T1D, is

Carvana shares on pace for 10% weekly loss as Mark Walter probe fuels investor jitters
The scrutiny raised questions about what could happen to Walter's Carvana position if fallout from the investigation pressures him to raise cash.

Moderna Stock Eyes Best Day Ever After Cancer Vaccine Breakthrough
Moderna Inc (NASDAQ:MRNA) is powering up the Nasdaq this morning, last seen126.5% higher to trade at $142.61.

NNN REIT: A 5.37% Yielding Dividend Aristocrat That Just Raised Guidance Again
NNN REIT (NNN) offers a 5.37% yield, 69% payout ratio, and trades at 12.93x 2026 AFFO guidance after a pullback from its 52-week high. Q2 saw occupancy rise to 99.1%, AFFO and revenue beat expectation

Kaplan Fox is Investigating Coastal Financial Corporation (CCB) and Encourages Investors Who Suffered Losses to Contact the Firm
New York, New York--(Newsfile Corp. - August 19, 2026) - Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against Coastal Financial Corporation ("Coastal" or the "Company")